BPA call - next generation (RBIS) DME
Active Awarded Last action
- Contract number
- 75F40124F19009
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,465,924
Award facts
- Contract value 93% obligated
-
- $3,465,924.19 Current, with exercised options
- $3,710,963.63 Potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Calverton, MD 20705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $3,465,924 |
About this award
Booz Allen Hamilton Inc. received a Blanket Purchase Agreement (BPA) call award from the Food and Drug Administration (FDA) on May 28, 2024, for Next Generation Regulatory Business Information System (RBIS) Durable Medical Equipment (DME) support services. The contract is valued at approximately $3.7 million with a completion date of July 31, 2027, and operates under a labor-hours pricing structure. This award represents a task order call against the company's existing Multiple Award Schedule (MAS) vehicle, which streamlines FDA's procurement of professional services. The work will be performed in Calverton, Maryland, and does not carry a small business set-aside designation, reflecting Booz Allen Hamilton's status as a large business prime contractor.
The FDA awarded this contract to support modernization and operational enhancements of its durable medical equipment regulatory systems through the RBIS initiative. Booz Allen Hamilton brings substantial expertise in regulatory science, IT infrastructure, systems engineering, and data management—capabilities the firm has previously demonstrated across hundreds of millions in FDA task order awards focused on electronic submissions, regulatory optimization, and biomarker tracking systems. The engagement aligns with the FDA's broader digital transformation efforts to strengthen its regulatory processes and information management capabilities for medical device oversight.
Quick answers
Who was awarded contract 75F40124F19009?
75F40124F19009 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on May 28, 2024.
How much is contract 75F40124F19009 worth?
The government has obligated $3,465,924 on 75F40124F19009. Its potential value, with all options, is $3,710,964.
Is contract 75F40124F19009 an order under another contract?
Yes. 75F40124F19009 is a BPA call under GS35F386DA-75F40122A00013, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40124F19009 competed?
The extent of competition for 75F40124F19009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award